These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2393507)

  • 1. Propafenone (rythmol) for ventricular arrhythmias.
    Porterfield LM
    Adv Clin Care; 1990; 5(5):41. PubMed ID: 2393507
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiarrhythmic propafenone: improving patient outcomes.
    Brzozowski LA
    Dimens Crit Care Nurs; 1993; 12(3):116-22. PubMed ID: 8508716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propafenone for cardiac arrhythmias.
    Med Lett Drugs Ther; 1990 Apr; 32(816):37-8. PubMed ID: 2182990
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of propafenone in anti-arrhythmia treatment].
    Furlanello F; Bertoldi A
    G Ital Cardiol; 1993 Oct; 23(10):1017-28. PubMed ID: 8174857
    [No Abstract]   [Full Text] [Related]  

  • 5. [Propafenone in the treatment of high-risk ventricular arrhythmias].
    Pepi R; Rotatori D; Mori A; Nascimbeni F
    Clin Ter; 1986 Aug; 118(4):247-52. PubMed ID: 3757464
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of propafenone on arrhythmias induced by exertion in patients with ischemic cardiopathy].
    Patané S; Virga T; Giannetto M; Luzza F; Oreto G; Arrigo F
    G Ital Cardiol; 1987 Jul; 17(7):605-8. PubMed ID: 3678712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Propafenone. An antiarrhythmic agent for both ventricular and supraventricular arrhythmia].
    Madsen JK; Nielsen H; Madsen BK
    Ugeskr Laeger; 1988 Dec; 150(50):3132-3. PubMed ID: 3206724
    [No Abstract]   [Full Text] [Related]  

  • 8. Propafenone for cardiac arrhythmias.
    Birgersdotter-Green U
    Am J Med Sci; 1992 Feb; 303(2):123-8. PubMed ID: 1539611
    [No Abstract]   [Full Text] [Related]  

  • 9. [Propafenone: evaluation of antiarrhythmic efficacy in hyperkinetic ventricular arrhythmia using acute oral test].
    Boriani G; Capucci A; Balducelli M; Frabetti L; Marchesini B; Tomasi L; Ambrosioni E; Magnani B
    Cardiologia; 1988 Nov; 33(11):1061-7. PubMed ID: 2475253
    [No Abstract]   [Full Text] [Related]  

  • 10. [Propafenone on the way into a new world. Profile of the anti-arrhythmia agent].
    Michel D
    Fortschr Med; 1989 Apr; 107(13):81. PubMed ID: 2722109
    [No Abstract]   [Full Text] [Related]  

  • 11. Propafenone.
    Funck-Brentano C; Kroemer HK; Lee JT; Roden DM
    N Engl J Med; 1990 Feb; 322(8):518-25. PubMed ID: 2405273
    [No Abstract]   [Full Text] [Related]  

  • 12. Propafenone--a new agent for the treatment of ventricular arrhythmias.
    Grubb BP
    Am J Med Sci; 1989 Oct; 298(4):249-51. PubMed ID: 2679087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific drugs for specific ventricular arrhythmias: an evaluation of current therapy and the role of propafenone.
    Murtazam A; Campbell RW
    Eur Heart J; 1989 Sep; 10 Suppl E():41-7. PubMed ID: 2680501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Propafenone--a promising anti-arrhythmia agent?].
    Rozsíval V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1990; 33(4):359-63. PubMed ID: 2130480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propafenone for malignant ventricular arrhythmia: an analysis of the literature.
    Hernandez M; Reder RF; Marinchak RA; Rials SJ; Kowey PR
    Am Heart J; 1991 Apr; 121(4 Pt 1):1178-84. PubMed ID: 2008842
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of the anti-arrhythmic action of propafenone treatment and its influence on left ventricular function].
    Saitta A; Bonaiuto M; Mileto A; Oriti S; Cinquegrani M; Giordano G; Fodale P; Saitta M; Squadrito F
    Clin Ter; 1993 Apr; 142(4):351-60. PubMed ID: 8330479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
    Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raised serum levels of desipramine with the antiarrhythmic propafenone.
    Katz MR
    J Clin Psychiatry; 1991 Oct; 52(10):432-3. PubMed ID: 1938981
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
    Geibel A; Zehender M; Hohnloser S; Landsrath C; Meinertz T; Just H
    Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propafenone monitoring in patients with refractory ventricular arrhythmias.
    Arranz Peña MI; Moro C
    J Pharm Biomed Anal; 1989; 7(12):1915-8. PubMed ID: 2490583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.